Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters








Database
Language
Publication year range
1.
Diabet Med ; 33(5): 668-73, 2016 May.
Article in English | MEDLINE | ID: mdl-26173465

ABSTRACT

AIMS: To determine if children and young people aged < 23 years with Type 1 diabetes differ in academic ability from age-matched control subjects without Type 1 diabetes and whether academic scores are related to glycaemic control. METHODS: Using a cross-sectional study design, we administered cognitive and academic tests (Woodcock-Johnson III Spatial Relations, General Information, Letter-Word Recognition, Calculation and Spelling tests) to young people with Type 1 diabetes (n=61) and control subjects (n=26) aged 9-22 years. The groups did not differ in age or gender. Participants with Type 1 diabetes had a disease duration of 5-17.7 years. History of glycaemic control (HbA1c , diabetic ketoacidosis and severe hypoglycaemic episodes) was obtained via medical records and interviews. RESULTS: The participants with Type 1 diabetes had a lower mean estimated verbal intelligence (IQ) level compared with those in the control group (P=0.04). Greater exposure to hyperglycaemia over time was associated with lower spelling abilities within the group with Type 1 diabetes (P=0.048), even after controlling for age, gender, socio-economic status, blood glucose level at time of testing and verbal IQ (P=0.01). History of severe hypoglycaemia or ketoacidosis was not associated with differences in academic abilities. CONCLUSIONS: In children and young people, Type 1 diabetes was associated with a lower verbal IQ. Moreover, increased exposure to hyperglycaemia was associated with lower spelling performance. These results imply that hyperglycaemia can affect cognitive function and/or learning processes that may affect academic achievement.


Subject(s)
Cognition Disorders/prevention & control , Diabetes Mellitus, Type 1/drug therapy , Educational Status , Hyperglycemia/prevention & control , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Learning Disabilities/prevention & control , Adolescent , Adolescent Development/drug effects , Adult , Child , Child Development/drug effects , Cognition/drug effects , Cognition Disorders/complications , Cognition Disorders/epidemiology , Cross-Sectional Studies , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/complications , Female , Glycated Hemoglobin/analysis , Humans , Hypoglycemia/epidemiology , Hypoglycemia/prevention & control , Intelligence/drug effects , Learning Disabilities/complications , Learning Disabilities/epidemiology , Male , Missouri/epidemiology , Risk , Young Adult
2.
Diabet Med ; 31(12): e33-6, 2014 Dec.
Article in English | MEDLINE | ID: mdl-24805141

ABSTRACT

BACKGROUND: Coeliac disease is an autoimmune disorder classically characterized by gastrointestinal symptoms and poor growth. The disease can be difficult to recognize in patients with Type 1 diabetes mellitus. Some clinicians find treatment of the disease in asymptomatic individuals controversial. CASE REPORTS: Two adolescent female patients with Type 1 diabetes experienced recurrent hypoglycaemic seizures. Neither patient reported gastrointestinal symptoms or poor growth. After diagnosis and treatment of coeliac disease, hypoglycaemia resolved. CONCLUSION: These cases illustrate how frequent unexplained severe hypoglycaemia can be an atypical presentation of coeliac disease in youth with Type 1 diabetes. Furthermore, they emphasize the importance of screening and treatment of coeliac disease in asymptomatic patients with Type 1 diabetes. Although controversial, management of coeliac disease in these asymptomatic patients can prevent the vicious cycle of recurrent hypoglycaemia and decrease risk for morbidity and death.


Subject(s)
Celiac Disease/complications , Diabetes Mellitus, Type 1/complications , Hypoglycemia/etiology , Seizures/etiology , Adolescent , Celiac Disease/diagnosis , Female , Humans , Severity of Illness Index
3.
Diabet Med ; 30(4): e151-6, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23330574

ABSTRACT

BACKGROUND: Hypoglycaemic events can be a serious complication of insulin therapy in Type 1 diabetes mellitus. Severe hypoglycaemic exposure can lead to episodic memory impairments, including anterograde amnesia. However, relatively little is known regarding the long-term impact of severe hypoglycaemia on brain structure in Type 1 diabetes mellitus. The goals of the present study were to gain a greater understanding of the long-term effects of severe hypoglycaemia exposure on brain structure and the neural correlates of memory impairments in Type 1 diabetes mellitus. CASE REPORT: Regional grey and white matter volume and total white matter lesion volume were quantified in an individual with long-standing hypoglycaemia-induced anterograde amnesia and compared with age- and gender-matched healthy controls. Our patient has significant reductions in grey matter volume in the hippocampus, thalamus and pallidum, and significant reductions in white matter volume in the splenium, isthmus of the cingulate and cerebellum. He also has a significantly larger total white matter lesion volume than controls. CONCLUSION: This case study highlights the potential of hypoglycaemia for permanent deleterious effects on brain structure and memory function. Our results suggest that subcortical grey matter, periventricular white matter and posterior white matter may be most susceptible to injury from hypoglycaemia exposure, and that structural damage to the hippocampus and isthmus of the cingulate may play a central role in hypoglycaemia-induced memory impairments.


Subject(s)
Brain Diseases/psychology , Diabetes Mellitus, Type 1/psychology , Hypoglycemia/psychology , Adult , Amnesia, Anterograde , Brain Diseases/pathology , Case-Control Studies , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 1/pathology , Humans , Hypoglycemia/pathology , Hypoglycemic Agents/adverse effects , Intelligence , Magnetic Resonance Imaging , Male , Neurologic Examination , Organ Size
4.
Crit Rev Oncog ; 10(1-2): 17-81, 1999.
Article in English | MEDLINE | ID: mdl-10327210

ABSTRACT

This review addresses the role of acute retroviruses in oncogenesis and the molecular mechanisms of viral carcinogenesis.


Subject(s)
Cell Transformation, Neoplastic , Oncogenes , Retroviridae/genetics , Animals , Humans , Oncogene Proteins/genetics , Oncogene Proteins/metabolism , Proto-Oncogenes
SELECTION OF CITATIONS
SEARCH DETAIL